Science · 10 Nov
CSIR-CCMB team identifies potential new targets to fight Tuberculosis
AI summaryA team of scientists at the CSIR-Centre for Cellular and Molecular Biology (CCMB) in Hyderabad identified critical weaknesses in the bacterium that causes Tuberculosis (TB) using CRISPR-based gene-silencing technology. The discovery could lead to new treatments for drug-resistant TB, a major public health challenge in India.
1 outlet